Skip to main content
Top
Published in: Tumor Biology 8/2015

01-08-2015 | Research Article

Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer

Authors: Mingqiang Kang, Yonghua Sang, Haiyong Gu, Liang Zheng, Liming Wang, Chao Liu, Yijun Shi, Aizhong Shao, Guowen Ding, Suocheng Chen, Weifeng Tang, Jun Yin

Published in: Tumor Biology | Issue 8/2015

Login to get access

Abstract

Worldwide, rates of esophageal cancer have been keeping highly in recent decades. Genetic variants in multiple cellular pathways might play an important role in altering risk of esophageal carcinoma. In this study, long noncoding RNAs (lncRNAs) functional single nucleotide polymorphisms (SNPs) were investigated in Chinese Han populations. We have genotyped the ANRIL rs2151280 T/C, POLR2E rs3787016 C/T, and HULC rs7763881 A/C SNPs in 380 esophageal squamous cell carcinoma (ESCC) cases and 380 cancer-free controls. POLR2E rs3787016 C/T was associated with a significantly decreased risk for ESCC (CT vs. CC: OR 0.62, 95 % CI 0.44–0.87, P = 0.005; adjusted OR 0.62, 95 % CI 0.44–0.87, P = 0.005). The other SNP, HULC rs7763881, also showed a suggestive association (AC vs. AA: OR 0.70, 95 % CI 0.50–0.98, P = 0.037; adjusted OR 0.69, 95 % CI 0.49–0.97, P = 0.031). ANRIL rs2151280 T/C SNP was not associated with risk of ESCC. In the future, larger studies with other ethnic populations, tissue-specific biological characterization, and detailed individual information should be undertaken to validate current findings.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.CrossRefPubMedPubMedCentral Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.CrossRefPubMedPubMedCentral
2.
go back to reference Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39:925–38.CrossRefPubMedPubMedCentral Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell. 2010;39:925–38.CrossRefPubMedPubMedCentral
3.
go back to reference Lakhotia SC. Long non-coding RNAs coordinate cellular responses to stress. Wiley Interdisciplin Rev RNA. 2012;3:779–96.CrossRef Lakhotia SC. Long non-coding RNAs coordinate cellular responses to stress. Wiley Interdisciplin Rev RNA. 2012;3:779–96.CrossRef
5.
go back to reference Bierhoff H, Schmitz K, Maass F, Ye J, Grummt I. Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harb Symp Quant Biol. 2010;75:357–64.CrossRefPubMed Bierhoff H, Schmitz K, Maass F, Ye J, Grummt I. Noncoding transcripts in sense and antisense orientation regulate the epigenetic state of ribosomal RNA genes. Cold Spring Harb Symp Quant Biol. 2010;75:357–64.CrossRefPubMed
6.
go back to reference Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. Lincrnas act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477:295–300.CrossRefPubMedPubMedCentral Guttman M, Donaghey J, Carey BW, Garber M, Grenier JK, Munson G, et al. Lincrnas act in the circuitry controlling pluripotency and differentiation. Nature. 2011;477:295–300.CrossRefPubMedPubMedCentral
7.
9.
go back to reference Morris KV. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenet : Off J DNA Methylation Soc. 2009;4:296–301.CrossRef Morris KV. Long antisense non-coding RNAs function to direct epigenetic complexes that regulate transcription in human cells. Epigenet : Off J DNA Methylation Soc. 2009;4:296–301.CrossRef
10.
go back to reference Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;40:2004–12.PubMed Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu S, et al. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol. 2012;40:2004–12.PubMed
12.
go back to reference Dereure O. Role of non-coding RNA ANRIL in the genesis of plexiform neurofibromas in neurofibromatosis type 1. Ann Dermatol Venereol. 2012;139:421–2.CrossRefPubMed Dereure O. Role of non-coding RNA ANRIL in the genesis of plexiform neurofibromas in neurofibromatosis type 1. Ann Dermatol Venereol. 2012;139:421–2.CrossRefPubMed
13.
go back to reference Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25:1086–95.CrossRefPubMedPubMedCentral Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G, et al. Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013;25:1086–95.CrossRefPubMedPubMedCentral
14.
go back to reference Yang G, Lu X, Yuan L. LncRNA: A link between RNA and cancer. Biochim Biophys Acta. 1839;2014:1097–109. Yang G, Lu X, Yuan L. LncRNA: A link between RNA and cancer. Biochim Biophys Acta. 1839;2014:1097–109.
15.
go back to reference Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 2011;32:1655–9.CrossRefPubMedPubMedCentral Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, et al. Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 2011;32:1655–9.CrossRefPubMedPubMedCentral
16.
go back to reference Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;132:330–42.CrossRefPubMed Panzitt K, Tschernatsch MM, Guelly C, Moustafa T, Stradner M, Strohmaier HM, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology. 2007;132:330–42.CrossRefPubMed
17.
go back to reference Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145.CrossRefPubMedPubMedCentral Liu Y, Pan S, Liu L, Zhai X, Liu J, Wen J, et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One. 2012;7:e35145.CrossRefPubMedPubMedCentral
18.
go back to reference Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.CrossRefPubMed Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.CrossRefPubMed
19.
go back to reference Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.CrossRefPubMed Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. MiR-196a2 rs11614913 T > C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.CrossRefPubMed
20.
go back to reference Schaeffeler E, Zanger UM, Eichelbaum M, Asante-Poku S, Shin JG, Schwab M. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: Reliable genotyping in different ethnic groups. Clin Chem. 2008;54:1637–47.CrossRefPubMed Schaeffeler E, Zanger UM, Eichelbaum M, Asante-Poku S, Shin JG, Schwab M. Highly multiplexed genotyping of thiopurine s-methyltransferase variants using MALD-TOF mass spectrometry: Reliable genotyping in different ethnic groups. Clin Chem. 2008;54:1637–47.CrossRefPubMed
22.
go back to reference Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. Creb up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38:5366–83.CrossRefPubMedPubMedCentral Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. Creb up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38:5366–83.CrossRefPubMedPubMedCentral
23.
go back to reference Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33:717–26.CrossRefPubMedPubMedCentral Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, et al. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol Cell. 2009;33:717–26.CrossRefPubMedPubMedCentral
Metadata
Title
Long noncoding RNAs POLR2E rs3787016 C/T and HULC rs7763881 A/C polymorphisms are associated with decreased risk of esophageal cancer
Authors
Mingqiang Kang
Yonghua Sang
Haiyong Gu
Liang Zheng
Liming Wang
Chao Liu
Yijun Shi
Aizhong Shao
Guowen Ding
Suocheng Chen
Weifeng Tang
Jun Yin
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 8/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-3328-z

Other articles of this Issue 8/2015

Tumor Biology 8/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine